A cost-effective and sensitive TLC-densitometric identification of meloxicam

Wioletta Parys 1 , Alina Pyka-Pająk 1 ,  and Małgorzata Dołowy 1
  • 1 Department of Analytical Chemistry Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200, Sosnowiec, Poland


The influence of different chromatographic conditions and the process of spot visualization on determining the limit of detection as well as quantification (LOD and LOQ) of meloxicam by TLC-densitometric technique was estimated. Of all chromatographic conditions tested, the lowest limiting values, thus the best sensitivity, in the NP-TLC system was achieved on silica gel 60F254 and neutral aluminum oxide plates developed with the mobile phase consisting of ethyl acetate/toluene/n-butylamine (2:2:1, V/V/V). In the case of the RP-TLC method, a mixture of methanol/water (8:2, V/V) enabled densitometric detection of meloxicam at the lowest concentration level on RP-8F254 and RP-18F254 plates. Additionally, the smallest LOD value of meloxicam ensured crystalline violet and gentian violet as visualization agents on silica gel 60F254 and neutral aluminum oxide 150F254 plates, resp. Comparison of the densitometrically obtained spectra of meloxicam drug and its standard after the use of appropriate visualization agents could be a good and cheap alternative tool for the identification of meloxicam as an active pharmaceutical ingredient.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. A. Walsem, R. Nixon, P. Guyot, A. Karabis and A. R. Moore, Relative benefit-risk comparing diclofe nac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis, Arthritis Res. Ther. 19 (2015) 66–72; https://doi.org/10.1186/s13075-015-0554-0

  • 2. A. Pyka, Detection progress of selected drugs in TLC, Biomed. Res. Int. 2014 (2014) Article ID 732078 (19 pages); https://doi.org/10.1155/2014/732078

  • 3. M. Dołowy and A. Pyka-Pająk, Development of new procedures for the detection and separation of salicylic acid and acetylsalicylic acid using thin-layer chromatography with densitometry, J. Planar Chromatogr. – Modern TLC 30 (2017) 363–374; https://doi.org/10.1556/1006.2017.30.5.5

  • 4. W. Parys, K. Bober, A. Pyka-Pająk and M. Dołowy, The application of TLC and densitometry for quantitative determination of meloxicam in tablets, Curr. Pharm. Anal. 15 (2019) 785–794; https://doi.org/10.2174/1573412915666190212155740

  • 5. M. Starek and J. Krzek, TLC determination of meloxicam in tablets and after acidic and alkaline hydrolysis, Acta Pol. Pharm. Drug Res. 69 (2012) 225–235.

  • 6. N. Desai and P. Amin, Stability indicating HPTLC determination of meloxicam, Indian J. Pharm. Sci. 70 (2008) 644–647; https://doi.org/10.4103/0250-474X.45406

  • 7. M. Starek, Separation and determination of four oxicams in pharmaceutical formulations by thin-layer chromatographic-densitometric method, J. Planar Chromatogr. – Modern TLC 24 (2011) 367–372; https://doi.org/10.1556/JPC.24.2011.5.1

  • 8. H. Hopkała and A. Pomykalski, TLC analysis of inhibitors of cyclooxygenase and videodensitometric determination of meloxicam and tiaprofenic acid, J. Planar Chromatogr. – Modern TLC 16 (2003) 107–111; https://doi.org/10.1556/JPC.16.2003.2.4

  • 9. J. Shaji and D. Varkey, Development of a validated stability-indicating HPTLC method for determination of meloxicam in bulk and pharmaceutical formulations: Pertinence to ICH guidelines, Int. J. Pharm. Pharm. Sci. 4 (2012) 160–169.

  • 10. B. Mamatha, G. Ushasree and V. U. Maheswara Rao, Analytical techniques for estimation of meloxicam in bulk and pharmaceutical dosage forms: A review, Int. J. Pharm. Res. Anal. 5 (2015) 74–77.

  • 11. A. Noreen, S. Ahmed, Z. Anwar and I. Ahmad, Analytical techniques for determination of meloxicam in pharmaceutical formulations and biological samples, Baqai J. Health Sci. 19 (2016) 59–74.

  • 12. International Conference of Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R1), ICH, Geneva 2005; http://www.ich.org; last access date March 15, 2019.


Journal + Issues